Related Topics
Reflecting on racism, public health, and social change in a difficult year
In a year marked by the collective trauma of the COVID-19 pandemic, and increased public reckoning around racism in the U.S., the 2021 Health Equity and Leadership (HEAL) Conference at Harvard Chan School kicked off with a call…
Coronavirus (COVID-19): Press Conference with Vish Viswanath, 05/12/21
You're listening to a press conference from the Harvard T.H. Chan School of Public Health with Vish Viswanath, director of the India Research Center, Lee Kum Kee Professor of Health Communication in the Department of Social and…
Helping medical providers discuss COVID-19 vaccines with hesitant patients
A new toolkit created by a team at Ariadne Labs aims to help increase public confidence in COVID-19 vaccines.
Leading coronavirus scientist, Kizzmekia S. Corbett, to join Harvard T.H. Chan School of Public Health to continue vaccine development research
Leading coronavirus scientist Kizzmekia S. Corbett is joining Harvard Chan School as an assistant professor to continue vaccine development research.
Coronavirus (COVID-19): Press Conference with Evan Benjamin, 05/07/21
You're listening to a press conference from the Harvard T.H. Chan School of Public Health with Evan Benjamin, associate professor in the Department of Health Policy and Management and chief medical officer of Ariadne Labs, a joint center…
How to flourish in the wake of the pandemic
Experts discussed ways that people can boost their overall well-being after the trauma, isolation, and grief of the COVID-19 pandemic.
The making of a disease detective
Samantha Giffen, PhD ’21, loves the thrill of discovery, in the lab and beyond.
For one Indian researcher, the fight for cleaner air is personal
Bhargav Krishna, DrPH ’21, hopes to build public support for improving India's ‘really terrible’ air.
Nurses key to delivering vaccines in developing countries
At a nursing leadership event, speakers cited nurses' critical role in vaccination campaigns, and called for vaccine equity among wealthy and developing nations.
Questions persist about COVID-19’s ‘chapter two’
More than a year into the COVID-19 pandemic, the world is at a pivotal moment.